EMPEROR-Reduced: confirming sodium-glucose co-transporter 2 inhibitors as an essential treatment for patients with heart failure with reduced ejection fraction. | Eur J Heart Fail;22(11): 1987-1990, 2020 11. | MEDLINE

Main content 1 Search 2 Footer 3

+A A -A High contrast

VHL Regional Portal

Information and Knowledge for Health

Advanced Search EVID@Easy

EMPEROR-Reduced: confirming sodium-glucose co-transporter 2 inhibitors as an essential treatment for patients with heart failure with reduced ejection fraction.

McMurray, John J V.

Affiliation

McMurray JJV; BHF Cardiovascular Research Centre, University of Glasgow, Glasgow, UK.

Eur J Heart Fail ; 22(11): 1987-1990, 2020 11.

Article in En | MEDLINE | ID: mdl-32946169

Subject(s)

Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Sodium-Glucose Transporter 2 Inhibitors / Heart Failure Type of study: Clinical_trials Limits: Aged / Female / Humans / Male Language: En Journal: Eur J Heart Fail Journal subject: CARDIOLOGIA Year: 2020 Document type: Article Affiliation country:

Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Sodium-Glucose Transporter 2 Inhibitors / Heart Failure Type of study: Clinical_trials Limits: Aged / Female / Humans / Male Language: En Journal: Eur J Heart Fail Journal subject: CARDIOLOGIA Year: 2020 Document type: Article Affiliation country: